Kang Zhou
- Structural Biology top 10%
- Biomaterials top 10%
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments 3
-
- MRI in cancer diagnosis 3
-
- Enzyme Structure and Function 3
-
- Bacteriophages and microbial interactions 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- Alzheimer's disease research and treatments 3
-
- Liver Disease Diagnosis and Treatment 3
-
- interferon and immune responses 2
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Nucleic Acids Research (1 paper)Journal of Biological Chemistry (3 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Kang Zhou
38 papers receiving 902 citations
Peers
Comparison fields: 5 of 106
- Structural Biology 16
- Biomaterials 124
- Neurology 129
- Infectious Diseases 111
- Oncology 143
Countries citing papers authored by Kang Zhou
This map shows the geographic impact of Kang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang Zhou more than expected).
Fields of papers citing papers by Kang Zhou
This network shows the impact of papers produced by Kang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang Zhou. The network helps show where Kang Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kang Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 19 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2020 | 137 | |
| 7 | 2020 | 21 | |
| 8 | 2020 | 8 | |
| 9 | 2020 | 51 | |
| 10 | 2019 | 8 | |
| 11 | 2016 | 5 | |
| 12 | 2015 | 20 | |
| 13 | 2014 | 26 | |
| 14 | 2013 | 5 | |
| 15 | 2013 | 6 | |
| 16 | [The effects of ezrin on the proliferation and the invasiveness of cells of different hepatocellular carcinoma cell lines]. | 2006 | 3 |
| 17 | 2006 | 2 | |
| 18 | 2006 | 32 | |
| 19 | 2006 | 37 | |
| 20 | 2004 | 13 |
About Kang Zhou
Kang Zhou is a scholar working on Structural Biology, Biochemistry and Hepatology, having authored 39 papers that have together received 910 indexed citations. Recurring topics across this work include MRI in cancer diagnosis (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Enzyme Structure and Function (3 papers), Bacteriophages and microbial interactions (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Alzheimer's disease research and treatments (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Structural Biology (16 citations), Biomaterials (124 citations) and Neurology (129 citations). Kang Zhou has collaborated with scholars based in China, United States and India. Frequent co-authors include Z. Hong Zhou, Cong‐Zhao Zhou, Yuxing Chen, Dayong Jin, Chuanqi Sun, M.R. Sawaya, Weifang Li, Lin Jiang, Michael P. Hughes and David R. Boyer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.